These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 16249247

  • 1. Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity.
    Leaños-Miranda A, Cárdenas-Mondragón G.
    Rheumatology (Oxford); 2006 Jan; 45(1):97-101. PubMed ID: 16249247
    [Abstract] [Full Text] [Related]

  • 2. Elevated bioactive prolactin levels in systemic lupus erythematosus--association with disease activity.
    Pacilio M, Migliaresi S, Meli R, Ambrosone L, Bigliardo B, Di Carlo R.
    J Rheumatol; 2001 Oct; 28(10):2216-21. PubMed ID: 11669159
    [Abstract] [Full Text] [Related]

  • 3. Elevated serum bioactive prolactin concentrations in patients with systemic lupus erythematosus are associated with disease activity as disclosed by homologous receptor bioassays.
    Cárdenas-Mondragón G, Ulloa-Aguirre A, Isordia-Salas I, Goffin V, Leaños-Miranda A.
    J Rheumatol; 2007 Jul; 34(7):1514-21. PubMed ID: 17516622
    [Abstract] [Full Text] [Related]

  • 4. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus.
    Leaños-Miranda A, Chávez-Rueda KA, Blanco-Favela F.
    Arthritis Rheum; 2001 Apr; 44(4):866-75. PubMed ID: 11315926
    [Abstract] [Full Text] [Related]

  • 5. Antiprolactin autoantibodies in systemic lupus erythematosus: frequency and correlation with prolactinemia and disease activity.
    Leaños-Miranda A, Pascoe-Lira D, Chávez-Rueda KA, Blanco-Favela F.
    J Rheumatol; 2001 Jul; 28(7):1546-53. PubMed ID: 11469460
    [Abstract] [Full Text] [Related]

  • 6. Hyperprolactinemia in males with systemic lupus erythematosus.
    Mok CC, Lau CS, Lee KW, Wong RW.
    J Rheumatol; 1998 Dec; 25(12):2357-63. PubMed ID: 9858430
    [Abstract] [Full Text] [Related]

  • 7. Prolactin hormone in juvenile systemic lupus erythematosus: a possible relationship to disease activity and CNS manifestations.
    El-Garf A, Salah S, Shaarawy M, Zaki S, Anwer S.
    J Rheumatol; 1996 Feb; 23(2):374-7. PubMed ID: 8882050
    [Abstract] [Full Text] [Related]

  • 8. Correlation of prolactin serum concentrations with clinical activity and remission in patients with systemic lupus erythematosus. Effect of conventional treatment.
    Vera-Lastra O, Mendez C, Jara LJ, Cisneros M, Medina G, Ariza R, Espinoza LR.
    J Rheumatol; 2003 Oct; 30(10):2140-6. PubMed ID: 14528507
    [Abstract] [Full Text] [Related]

  • 9. No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus.
    Buskila D, Lorber M, Neumann L, Flusser D, Shoenfeld Y.
    J Rheumatol; 1996 Apr; 23(4):629-32. PubMed ID: 8730116
    [Abstract] [Full Text] [Related]

  • 10. [Hyperprolactinemia in systemic lupus erythematosus. A prospective study of 38 cases].
    Smiti Khanfir M, Ben Ghorbel I, Feki M, Lamloum M, Mebazaa A, Miled M, Houman MH.
    Tunis Med; 2004 Jun; 82(6):512-5. PubMed ID: 15517949
    [Abstract] [Full Text] [Related]

  • 11. Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases.
    Neidhart M.
    J Rheumatol; 1996 Mar; 23(3):476-81. PubMed ID: 8832986
    [Abstract] [Full Text] [Related]

  • 12. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
    Szekanecz E, Szucs G, Szekanecz Z, Tarr T, Antal-Szalmás P, Szamosi S, Szántó J, Kiss E.
    J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
    [Abstract] [Full Text] [Related]

  • 13. Anti-prolactin autoantibodies in pregnant women with systemic lupus erythematosus: maternal and fetal outcome.
    Leaños-Miranda A, Cárdenas-Mondragón G, Ulloa-Aguirre A, Isordia-Salas I, Parra A, Ramírez-Peredo J.
    Lupus; 2007 Dec; 16(5):342-9. PubMed ID: 17576736
    [Abstract] [Full Text] [Related]

  • 14. Altered diurnal rhythm of prolactin in systemic sclerosis.
    Hilty C, Brühlmann P, Sprott H, Gay RE, Michel BA, Gay S, Neidhart M.
    J Rheumatol; 2000 Sep; 27(9):2160-5. PubMed ID: 10990228
    [Abstract] [Full Text] [Related]

  • 15. Correlation of serum prolactin levels and disease activity in systematic lupus erythematosus.
    Karimifar M, Tahmasebi A, Bonakdar ZS, Purajam S.
    Rheumatol Int; 2013 Feb; 33(2):511-6. PubMed ID: 22065074
    [Abstract] [Full Text] [Related]

  • 16. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
    de Carvalho JF, Borba EF, Viana VS, Bueno C, Leon EP, Bonfá E.
    Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371
    [Abstract] [Full Text] [Related]

  • 17. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Feng X, Wu H, Grossman JM, Hanvivadhanakul P, FitzGerald JD, Park GS, Dong X, Chen W, Kim MH, Weng HH, Furst DE, Gorn A, McMahon M, Taylor M, Brahn E, Hahn BH, Tsao BP.
    Arthritis Rheum; 2006 Sep; 54(9):2951-62. PubMed ID: 16947629
    [Abstract] [Full Text] [Related]

  • 18. Prolactin and thyroid hormones in patients with systemic sclerosis: correlations with disease manifestations and activity.
    Shahin AA, Abdoh S, Abdelrazik M.
    Z Rheumatol; 2002 Dec; 61(6):703-9. PubMed ID: 12491136
    [Abstract] [Full Text] [Related]

  • 19. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
    Dhir V, Singh AP, Aggarwal A, Naik S, Misra R.
    Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
    [Abstract] [Full Text] [Related]

  • 20. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N, Kasama T, Isozaki T, Odai T, Matsunawa M, Negishi M, Ide H, Kameoka Y, Hirohata S, Adachi M.
    Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.